China's State Drug Administration Accepts PD-1 Telli-Zhu-Dan-Ri-Dan-Ri-Dan-Ri-Mono-Resistance Application

late last month, Burlinger Ingeheim partner Baiji Shenzhou(NMPA) of China's NationalMedicines
Administration (NMPA) has accepted its PD-1 Tilreju-Ju-Ri-Ju-Ri-Ri-Dan-Ri-Ri-Ri-Dana-ri applicationthe drug is the first innovative biopharmaceutical in the country to be marketed under the system of license holders of drugs under the licensing system of the pharmaceutical market, theof the Pharmaceuticalof the Chinese Bio
Pharmaceuticals (base) of Burlinger IngeheimSince 2013, Bollinger Ingelheim Biopharmaceutical Sorgerham Biopharmaceutical sororityProduct(Brand BioXcellence™ has provided chemical, production and control (CMC) management, process andanalysis(method development and global GMP (pharmaceutical production quality management practices) clinicaltrial and(drug production services) in CMC management for its drug registration declaration in China and global marketsJanuary 2018, Bollinger Ingerham signed a long-term(agreement) with BacchiShenson for the long-term supply of commercial products As part of the Baiji Shenzhou and Bollinger Ingeheim Exploration Practice "Drug Listing License Holder Stakes System", The Treli Pearl Monosantia will be produced at the world-class Bollinger Ingeheim biopharmaceutical production site in Shanghai The design, construction and operation of the base is in line with the current highest international standards and is equipped with the qualifications and capabilities to carry out bio
pharmaceutical (market supply) to all countries of the world The 2000-litre disposable bioreactor used in the commercial production of biopharmaceuticals is the world's largest disposable bioreactor the PD-1 Terri-Zuma-applying indication is Hodgkin's lymphoma, and the drug is also conducting clinical trials for the treatment of a variety of malignancies, including non-small cell lung cancer, hepatocellular carcinoma and esophageal squamous cell carcinoma Bollinger Ingerham China Biopharmaceuticals' team is committed to fully supporting Baiji Shenzhou by providing the world's highest quality standards for the benefit of patients